Celgene Settles Whistleblower Suit for $280 Million

27.07.2017 - US pharmaceutical company Celgene has agreed to pay $280 million to settle a whistleblower lawsuit accusing it of fraud for promoting a thalidomide-based drug pair re-purposed to...